{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:28:50Z","timestamp":1790972930879,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072979"],"award-info":[{"award-number":["P30AG072979"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG062418"],"award-info":[{"award-number":["U19AG062418"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F30AG063446"],"award-info":[{"award-number":["F30AG063446"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066506"],"award-info":[{"award-number":["P30AG066506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F30AG067673"],"award-info":[{"award-number":["F30AG067673"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS089022"],"award-info":[{"award-number":["R01NS089022"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100876"],"award-info":[{"award-number":["R01NS100876"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS129567"],"award-info":[{"award-number":["RF1NS129567"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS082168"],"award-info":[{"award-number":["T32NS082168"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jbc.2023.104912","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:38:47Z","timestamp":1686400727000},"page":"104912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cellular processing of \u03b1-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-8470","authenticated-orcid":false,"given":"Stephan","family":"Quintin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-7446","authenticated-orcid":false,"given":"Grace M.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-9848","authenticated-orcid":false,"given":"Giavanna","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-8256","authenticated-orcid":false,"given":"Yuxing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brach M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly-Marie","family":"Gorion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.104912_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2008.09.013","article-title":"Molecular mechanisms of alpha-synuclein neurodegeneration","volume":"1792","author":"Waxman","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2023.104912_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","article-title":"Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies","volume":"131","author":"Uchihara","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2023.104912_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jbc.2023.104912_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2023.104912_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s004010050917","article-title":"NACP\/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy","volume":"96","author":"Arima","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2023.104912_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-021-01173-y","article-title":"Robust alpha-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy","volume":"9","author":"Hass","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2023.104912_bib7","first-page":"879","article-title":"Aggregation of alpha-synuclein in lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2023.104912_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","article-title":"The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease","volume":"76","author":"Campbell","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2023.104912_bib9","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/srep05797","article-title":"Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry","volume":"4","author":"Kellie","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2023.104912_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","article-title":"alpha-synuclein phosphorylation and truncation are normal events in the adult human brain","volume":"200","author":"Muntane","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2023.104912_bib11","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104912_bib12","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib13","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.104912_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nbd.2014.10.011","article-title":"Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils","volume":"73","author":"Tsujimura","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2023.104912_bib15","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc. Natl. Acad. Sci.U. S. A."},{"key":"10.1016\/j.jbc.2023.104912_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbagen.2015.10.007","article-title":"Cellular response of human neuroblastoma cells to alpha-synuclein fibrils, the main constituent of Lewy bodies","volume":"1860","author":"Pieri","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2023.104912_bib17","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1074\/jbc.RA119.008930","article-title":"C-terminal alpha-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease","volume":"294","author":"McGlinchey","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jnc.13743","article-title":"Proteolysis of alpha-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology","volume":"140","author":"Sacino","year":"2017","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2023.104912_bib19","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","article-title":"Prying into the Prion Hypothesis for Parkinson's Disease","volume":"37","author":"Brundin","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2023.104912_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","article-title":"Evidence of distinct alpha-synuclein strains underlying disease heterogeneity","volume":"142","author":"Holec","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2023.104912_bib21","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of alpha-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib22","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1021\/acs.biochem.7b00360","article-title":"Taking a bite out of amyloid: mechanistic insights into alpha-synuclein degradation by cathepsin L","volume":"56","author":"McGlinchey","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.104912_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024380","article-title":"The transcellular propagation and intracellular trafficking of alpha-synuclein","volume":"7","author":"Tofaris","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jbc.2023.104912_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40478-021-01242-2","article-title":"Disease-, region- and cell type specific diversity of alpha-synuclein carboxy terminal truncations in synucleinopathies","volume":"9","author":"Hass","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2023.104912_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5280","article-title":"The vermiform appendix impacts the risk of developing Parkinson's disease","volume":"10","author":"Killinger","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2023.104912_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01949.x","article-title":"A\u00a0comparison of amyloid fibrillogenesis using the novel fluorescent compound K114","volume":"86","author":"Crystal","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2023.104912_bib27","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in\u00a0vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.104912_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-022-02425-4","article-title":"Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice","volume":"143","author":"Lloyd","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2023.104912_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-021-00486-9","article-title":"Collusion of alpha-Synuclein and Abeta aggravating co-morbidities in a novel prion-type mouse model","volume":"16","author":"Lloyd","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2023.104912_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1750-3639.2012.00597.x","article-title":"Critical role of truncated alpha-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease","volume":"22","author":"Prasad","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jbc.2023.104912_bib31","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein alpha-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104912_bib32","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.jmb.2019.07.001","article-title":"Structural Insights into alpha-Synuclein fibril polymorphism: effects of Parkinson's disease-related C-terminal truncations","volume":"431","author":"Ni","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.104912_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2023.104912_bib34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.104912_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40478-019-0840-1","article-title":"Luminescent conjugated oligothiophenes distinguish between alpha-synuclein assemblies of Parkinson's disease and multiple system atrophy","volume":"7","author":"Klingstedt","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2023.104912_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"alpha-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2023.104912_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135017","article-title":"Carboxy-terminal truncation and phosphorylation of alpha-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy","volume":"732","author":"Sorrentino","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2023.104912_bib38","doi-asserted-by":"crossref","first-page":"18914","DOI":"10.1074\/jbc.RA118.005603","article-title":"Physiological carboxy-truncation of alpha-synuclein potentiates the prion-like formation of pathological inclusions","volume":"293","author":"Sorrentino","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib39","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","article-title":"Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies","volume":"56","author":"Moors","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2023.104912_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson's disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2023.104912_bib41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in\u00a0vitro","volume":"86","author":"Mishizen-Eberz","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2023.104912_bib42","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1039\/C8SC01109E","article-title":"C-terminal truncation of alpha-synuclein promotes amyloid fibril amplification at physiological pH","volume":"9","author":"van der Wateren","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jbc.2023.104912_bib43","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.1021\/jacs.7b07403","article-title":"C-Terminal truncated alpha-synuclein fibrils contain strongly twisted beta-sheets","volume":"139","author":"Iyer","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.104912_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.jbc.2023.104912_bib45","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104912_bib46","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A\u00a0precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib47","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1523\/JNEUROSCI.2102-14.2014","article-title":"Brain injection of alpha-Synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker","volume":"34","author":"Sacino","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2023.104912_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-016-0357-9","article-title":"Novel antibodies to phosphorylated alpha-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes","volume":"4","author":"Rutherford","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2023.104912_bib49","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A\u00a0hydrophobic stretch of 12 amino acid residues in the middle of alpha- synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104912_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","article-title":"A\u00a0novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation","volume":"113","author":"Waxman","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2023.104912_bib51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-014-1268-0","article-title":"Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice","volume":"127","author":"Sacino","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2023.104912_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0003-2697(86)90207-1","article-title":"Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies","volume":"157","author":"Dunn","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbc.2023.104912_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jbc.2023.104912_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2023.104912_bib55","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2023.104912_bib56","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41374-019-0198-9","article-title":"Dissecting alpha-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis","volume":"99","author":"Dhillon","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jbc.2023.104912_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184731","article-title":"A\u00a0novel panel of alpha-synuclein antibodies reveal distinctive staining profiles in synucleinopathies","volume":"12","author":"Dhillon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2023.104912_bib58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A\u00a0panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J.\u00a0Neurosci. Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:50:06Z","timestamp":1778637006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823019403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0021925823019403"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104912","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular processing of \u03b1-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"104912"}}